Ticagrelor monotherapy following percutaneous coronary intervention for acute coronary syndrome in TWILIGHT patients: still a future for aspirin?

Mattia Lunardi; Yoshinobu Onuma; Patrick W. Serruys

doi:10.1093/eurheartj/ehab037

Related publications

Article2023

TCT-165 Aspirin-Free Prasugrel Monotherapy: 30-Day Clinical Outcome After Percutaneous Coronary Intervention in Chronic Coronary Syndrome and Non–ST-Segment Elevation Acute Coronary Syndrome

Gaku Nakazawa, Kotaro Miyashita, Shinichiro Masuda, Akihiro Tobe, Pedro A. Lemos, Patrícia O. Guimarães, Takashi Muramatsu, Nozomi Kotoku, Shigetaka Kageyama, Kai Ninomiya, Kengo Tanabe, Yukio Ozaki, Ken Kozuma, Yoshinobu Onuma, Patrick W. Serruys

Journal of the American College of Cardiology

Article2025

Aspirin-Free Prasugrel Monotherapy After Percutaneous Coronary Intervention in Patients With Non-ST Elevation Acute Coronary Syndrome

Kotaro Miyashita, Takashi Muramatsu, Pruthvi C. Revaiah, Gaku Nakazawa, Yuki Ishibashi, Ken Kozuma, Taku Asano, Yuki Katagiri, Takayuki Okamura, Yoshihiro Morino, Norihiro Kogame, Masafumi Ono, Yosuke Miyazaki, Shimpei Nakatani, Masato Nakamura, Akihiro Tobe, Asahi Oshima, Tsung Ying-Tsai, Scot Garg, Kengo Tanabe, Yukio Ozaki, Patrick W. Serruys,

Article2021

TCT-201 Impact of Proton Pump Inhibitors on Efficacy of Antiplatelet Strategies With Ticagrelor or Aspirin After Percutaneous Coronary Intervention

Masafumi Ono, Yoshinobu Onuma, Hideyuki Kawashima, Hironori Hara, Chao Gao, Rutao Wang, Neil O’Leary, Scot Garg, Peter Jüni, Christian Hamm, Marco Valgimigli, Stephan Windecker, Pascal Vranckx, Efthymios Deliargyris, Deepak L. Bhatt, Robert F. Storey, Patrick W. Serruys

Journal of the American College of Cardiology

Article2010

PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS POST SURGICAL REVASCULARISATION

Scot Garg, Giovanna Sarno, Juan Luis Gutiérrez‐Chico, Joanna J. Wykrzykowska, Chrysafios Girasis, Peter de Jaegere, Arie-Peter Kappetein, Ron van Domburg, Patrick W. Serruys

Journal of the American College of Cardiology

Article2006

Fluvastatin for Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention

Patrick W. Serruys, Pim de Feyter, Carlos Macaya, N. Kokott, Jean‐Luc Puel, Matthias Vrolix, Angelo Branzi, Marcelo Chiara Bertolami, Graham Jackson, Bradley H. Strauss, Bernhard Meier

Ticagrelor monotherapy following percutaneous coronary intervention for acute coronary syndrome in TWILIGHT patients: still a future for aspirin?

Abstract

Discussion(0)

Related publications

TCT-165 Aspirin-Free Prasugrel Monotherapy: 30-Day Clinical Outcome After Percutaneous Coronary Intervention in Chronic Coronary Syndrome and Non–ST-Segment Elevation Acute Coronary Syndrome

Aspirin-Free Prasugrel Monotherapy After Percutaneous Coronary Intervention in Patients With Non-ST Elevation Acute Coronary Syndrome

TCT-201 Impact of Proton Pump Inhibitors on Efficacy of Antiplatelet Strategies With Ticagrelor or Aspirin After Percutaneous Coronary Intervention

PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS POST SURGICAL REVASCULARISATION

Fluvastatin for Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention